Search
Displaying 81–90 of 735 for “retinitis clinical trial”
-
Atsena Receives FDA Authorization to Launch a Gene Therapy Clinical Trial for XLRS
Research NewsKnown as The Lighthouse Study, the Phase ½ trial is expected to begin in mid-2023
-
Encouraging Clinical Trial Results for Alkeus’ Stargardt Disease Treatment
Research NewsThe company is also conducting a Phase 3 clinical trial of the emerging therapy for geographic atrophy.
-
Allergan and Editas Begin Recruiting for CRISPR/Cas9 Clinical Trial for LCA10
Research NewsThe trial will be the first for a CRISPR/Cas9 therapy administered inside the human body.
-
Atsena Doses First Patient in XLRS Gene Therapy Clinical Trial
Research NewsThe AAV.SPR gene delivery system used in the trial is designed to more safely reach targeted retinal cells
-
Safety Clinical Trial Launched for Usher Syndrome 3 Drug
Research NewsResearchers hope the molecule will slow the vision and hearing loss associated with USH3.
-
Biogen’s Phase 3 Clinical Trial for its Choroideremia Gene Therapy Doesn’t Meet Endpoints
Research NewsAdditional results from the trial will be reported at a future scientific meeting
-
Research News
The company has also launched a natural history study of patients to inform the planned clinical trial.
-
Opus Reports Vision Improvements for Patients in LCA5 Gene Therapy Clinical Trial
Research NewsThe company plans to administer a higher dose of the emerging gene therapy to the next group of patients.
-
Atsena’s LCA-GUCY2D Gene Therapy Improves Vision in Phase 1/2 Clinical Trial
Research NewsThe company is planning to move the emerging treatment into a pivotal trial
-
Clinical Trial Authorized in the U.S. for Emerging LCA 10 Therapy
Research NewsProQR, a biotechnology company in the Netherlands, has received authorization from the U.S. Food and Drug Administration to start a Phase I/II clinical trial for its therapy known as QR-110
